{"entity":{"type":"insider","cik":"0001304113","url":"/insider/0001304113","json_url":"/insider/0001304113.json","name":"Powell Andrew Kenneth William","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":15,"first":"2005-06-27","last":"2024-03-05","span_basis":"filed_date"},"name_variants":[{"name":"Powell Andrew Kenneth William","source":"filing","n_filings":15,"first_seen":"2005-06-27","last_seen":"2024-03-05"}],"transactions":[{"id":2698342,"accession":"0001209191-24-004385","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-004385","line_url":"/filing/0001209191-24-004385#line-2","is_derivative":false,"issuer_cik":"0001304113","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001304113","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":7500.0,"total_display":"7,500.00","shares_owned_after":28863.0,"shares_owned_after_display":"28,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-05","scope":"insider"},{"id":2698337,"accession":"0001209191-24-004385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-24-004385","line_url":"/filing/0001209191-24-004385#line-1","is_derivative":false,"issuer_cik":"0001304113","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001304113","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8500.0,"shares_display":"8,500","price_per_share":1.23,"price_display":"1.23","price_state":"stated","total_value":10455.0,"total_display":"10,455.00","shares_owned_after":22863.0,"shares_owned_after_display":"22,863","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":8459993,"accession":"0001437749-19-000820","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-19-000820","line_url":"/filing/0001437749-19-000820#line-1","is_derivative":false,"issuer_cik":"0001005286","issuer_name":"LANDEC CORP \\CA\\","issuer_ticker":"LNDC","issuer_name_source":null,"issuer_url":"/issuer/0001005286","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":525.0,"shares_display":"525","price_per_share":11.62,"price_display":"11.62","price_state":"stated","total_value":6100.5,"total_display":"6,100.50","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-11","filed_date":"2019-01-14","scope":"insider"},{"id":6558190,"accession":"0001209191-18-031200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-031200","line_url":"/filing/0001209191-18-031200#line-1","is_derivative":false,"issuer_cik":"0001304113","issuer_name":"Aclaris Therapeutics, Inc.","issuer_ticker":"ACRS","issuer_name_source":null,"issuer_url":"/issuer/0001304113","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":19.12,"price_display":"19.12","price_state":"stated","total_value":9560.0,"total_display":"9,560.00","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-16","filed_date":"2018-05-17","scope":"insider"},{"id":2371242,"accession":"0001209191-16-126107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-126107","line_url":"/filing/0001209191-16-126107#line-1","is_derivative":false,"issuer_cik":"0001011835","issuer_name":"MEDIVATION, INC.","issuer_ticker":"MDVN","issuer_name_source":null,"issuer_url":"/issuer/0001011835","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (SVP, General Counsel & Crp Sec)","officer_title":"SVP, General Counsel & Crp Sec","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2578.0,"shares_display":"2,578","price_per_share":60.42,"price_display":"60.42","price_state":"stated","total_value":155762.76,"total_display":"155,762.76","shares_owned_after":28517.0,"shares_owned_after_display":"28,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-06","filed_date":"2016-06-06","scope":"insider"},{"id":6593167,"accession":"0001209191-14-055396","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-055396","line_url":"/filing/0001209191-14-055396#line-2","is_derivative":false,"issuer_cik":"0001087432","issuer_name":"INTERMUNE INC","issuer_ticker":"ITMN","issuer_name_source":null,"issuer_url":"/issuer/0001087432","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (EVP, GC & Secretary)","officer_title":"EVP, GC & Secretary","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":73.4713,"price_display":"73.47","price_state":"stated","total_value":551034.75,"total_display":"551,034.75","shares_owned_after":30927.0,"shares_owned_after_display":"30,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-03","scope":"insider"},{"id":7093656,"accession":"0001209191-14-038851","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-038851","line_url":"/filing/0001209191-14-038851#line-3","is_derivative":false,"issuer_cik":"0001087432","issuer_name":"INTERMUNE INC","issuer_ticker":"ITMN","issuer_name_source":null,"issuer_url":"/issuer/0001087432","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (EVP, GC & Secretary)","officer_title":"EVP, GC & Secretary","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":39.3236,"price_display":"39.32","price_state":"stated","total_value":19661.8,"total_display":"19,661.80","shares_owned_after":31027.0,"shares_owned_after_display":"31,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-30","filed_date":"2014-06-03","scope":"insider"},{"id":7093654,"accession":"0001209191-14-038851","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-038851","line_url":"/filing/0001209191-14-038851#line-2","is_derivative":false,"issuer_cik":"0001087432","issuer_name":"INTERMUNE INC","issuer_ticker":"ITMN","issuer_name_source":null,"issuer_url":"/issuer/0001087432","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (EVP, GC & Secretary)","officer_title":"EVP, GC & Secretary","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":39.56,"price_display":"39.56","price_state":"stated","total_value":19780.0,"total_display":"19,780.00","shares_owned_after":31527.0,"shares_owned_after_display":"31,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-29","filed_date":"2014-06-03","scope":"insider"},{"id":8949060,"accession":"0001209191-11-039773","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-039773","line_url":"/filing/0001209191-11-039773#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CORNERSTONE THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":8.63,"price_display":"8.63","price_state":"stated","total_value":17260.0,"total_display":"17,260.00","shares_owned_after":98100.0,"shares_owned_after_display":"98,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-15","filed_date":"2011-07-18","scope":"insider"},{"id":9046262,"accession":"0001209191-11-021924","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-021924","line_url":"/filing/0001209191-11-021924#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CORNERSTONE THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":6.53,"price_display":"6.53","price_state":"stated","total_value":13060.0,"total_display":"13,060.00","shares_owned_after":100100.0,"shares_owned_after_display":"100,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-04","filed_date":"2011-04-06","scope":"insider"},{"id":9123439,"accession":"0001209191-11-002642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-002642","line_url":"/filing/0001209191-11-002642#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CORNERSTONE THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":5.73,"price_display":"5.73","price_state":"stated","total_value":11460.0,"total_display":"11,460.00","shares_owned_after":102100.0,"shares_owned_after_display":"102,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-01-07","filed_date":"2011-01-10","scope":"insider"},{"id":7639386,"accession":"0001209191-10-052636","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-052636","line_url":"/filing/0001209191-10-052636#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CORNERSTONE THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (EVP, General Counsel)","officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7900.0,"shares_display":"7,900","price_per_share":6.28,"price_display":"6.28","price_state":"stated","total_value":49612.0,"total_display":"49,612.00","shares_owned_after":104100.0,"shares_owned_after_display":"104,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-01","filed_date":"2010-11-02","scope":"insider"},{"id":7948604,"accession":"0001179110-07-022435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-022435","line_url":"/filing/0001179110-07-022435#line-1","is_derivative":false,"issuer_cik":"0001012270","issuer_name":"COLLAGENEX PHARMACEUTICALS INC","issuer_ticker":"CGPI","issuer_name_source":null,"issuer_url":"/issuer/0001012270","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (VP, G. Counsel and Corp. Sec)","officer_title":"VP, G. Counsel and Corp. Sec.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":7.3,"price_display":"7.30","price_state":"stated","total_value":1460.0,"total_display":"1,460.00","shares_owned_after":3850.0,"shares_owned_after_display":"3,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-11-28","filed_date":"2007-11-30","scope":"insider"},{"id":7165968,"accession":"0001179110-07-021913","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-021913","line_url":"/filing/0001179110-07-021913#line-1","is_derivative":false,"issuer_cik":"0001012270","issuer_name":"COLLAGENEX PHARMACEUTICALS INC","issuer_ticker":"CGPI","issuer_name_source":null,"issuer_url":"/issuer/0001012270","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (VP, G. Counsel and Corp. Sec)","officer_title":"VP, G. Counsel and Corp. Sec.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":8.01,"price_display":"8.01","price_state":"stated","total_value":3204.0,"total_display":"3,204.00","shares_owned_after":3650.0,"shares_owned_after_display":"3,650","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-20","scope":"insider"},{"id":7381513,"accession":"0001179110-07-021413","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-07-021413","line_url":"/filing/0001179110-07-021413#line-2","is_derivative":false,"issuer_cik":"0001012270","issuer_name":"COLLAGENEX PHARMACEUTICALS INC","issuer_ticker":"CGPI","issuer_name_source":null,"issuer_url":"/issuer/0001012270","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (VP, G. Counsel and Corp. Sec)","officer_title":"VP, G. Counsel and Corp. Sec.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250.0,"shares_display":"250","price_per_share":8.44,"price_display":"8.44","price_state":"stated","total_value":2110.0,"total_display":"2,110.00","shares_owned_after":3050.0,"shares_owned_after_display":"3,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-11-08","filed_date":"2007-11-13","scope":"insider"},{"id":7381512,"accession":"0001179110-07-021413","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-021413","line_url":"/filing/0001179110-07-021413#line-1","is_derivative":false,"issuer_cik":"0001012270","issuer_name":"COLLAGENEX PHARMACEUTICALS INC","issuer_ticker":"CGPI","issuer_name_source":null,"issuer_url":"/issuer/0001012270","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (VP, G. Counsel and Corp. Sec)","officer_title":"VP, G. Counsel and Corp. Sec.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":1700.0,"total_display":"1,700.00","shares_owned_after":3250.0,"shares_owned_after_display":"3,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-08","filed_date":"2007-11-13","scope":"insider"},{"id":7025951,"accession":"0001179110-07-011255","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-07-011255","line_url":"/filing/0001179110-07-011255#line-1","is_derivative":false,"issuer_cik":"0001012270","issuer_name":"COLLAGENEX PHARMACEUTICALS INC","issuer_ticker":"CGPI","issuer_name_source":null,"issuer_url":"/issuer/0001012270","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (VP, G. Counsel and Corp. Sec)","officer_title":"VP, G. Counsel and Corp. Sec.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":10.48,"price_display":"10.48","price_state":"stated","total_value":2096.0,"total_display":"2,096.00","shares_owned_after":2800.0,"shares_owned_after_display":"2,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-22","filed_date":"2007-05-24","scope":"insider"},{"id":9245946,"accession":"0001181431-05-036841","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-05-036841","line_url":"/filing/0001181431-05-036841#line-4","is_derivative":false,"issuer_cik":"0001012270","issuer_name":"COLLAGENEX PHARMACEUTICALS INC","issuer_ticker":"CGPI","issuer_name_source":null,"issuer_url":"/issuer/0001012270","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (VP, G. Counsel and Corp. Sec)","officer_title":"VP, G. Counsel and Corp. Sec.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.86,"price_display":"4.86","price_state":"stated","total_value":2430.0,"total_display":"2,430.00","shares_owned_after":2600.0,"shares_owned_after_display":"2,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-13","filed_date":"2005-06-27","scope":"insider"},{"id":9245945,"accession":"0001181431-05-036841","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-05-036841","line_url":"/filing/0001181431-05-036841#line-1","is_derivative":false,"issuer_cik":"0001012270","issuer_name":"COLLAGENEX PHARMACEUTICALS INC","issuer_ticker":"CGPI","issuer_name_source":null,"issuer_url":"/issuer/0001012270","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (VP, G. Counsel and Corp. Sec)","officer_title":"VP, G. Counsel and Corp. Sec.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":2450.0,"total_display":"2,450.00","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-06-10","filed_date":"2005-06-27","scope":"insider"},{"id":9245944,"accession":"0001181431-05-036841","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-05-036841","line_url":"/filing/0001181431-05-036841#line-2","is_derivative":false,"issuer_cik":"0001012270","issuer_name":"COLLAGENEX PHARMACEUTICALS INC","issuer_ticker":"CGPI","issuer_name_source":null,"issuer_url":"/issuer/0001012270","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (VP, G. Counsel and Corp. Sec)","officer_title":"VP, G. Counsel and Corp. Sec.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":1470.0,"total_display":"1,470.00","shares_owned_after":1600.0,"shares_owned_after_display":"1,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-06-10","filed_date":"2005-06-27","scope":"insider"},{"id":9245943,"accession":"0001181431-05-036841","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-05-036841","line_url":"/filing/0001181431-05-036841#line-3","is_derivative":false,"issuer_cik":"0001012270","issuer_name":"COLLAGENEX PHARMACEUTICALS INC","issuer_ticker":"CGPI","issuer_name_source":null,"issuer_url":"/issuer/0001012270","owner_cik":"0001304113","owner_name":"Powell Andrew Kenneth William","owner_url":"/insider/0001304113","role":"Officer (VP, G. Counsel and Corp. Sec)","officer_title":"VP, G. Counsel and Corp. Sec.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":2400.0,"total_display":"2,400.00","shares_owned_after":2100.0,"shares_owned_after_display":"2,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-10","filed_date":"2005-06-27","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001557746","name":"Aclaris Therapeutics, Inc.","url":"/issuer/0001557746","role":"Director","n_filings":2,"first_seen":"2018-05-17","last_seen":"2024-03-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001005286","name":"LANDEC CORP \\CA\\","url":"/issuer/0001005286","role":"Director","n_filings":1,"first_seen":"2019-01-14","last_seen":"2019-01-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001011835","name":"MEDIVATION, INC.","url":"/issuer/0001011835","role":"Officer (SVP, General Counsel & Crp Sec)","n_filings":1,"first_seen":"2016-06-06","last_seen":"2016-06-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001087432","name":"INTERMUNE INC","url":"/issuer/0001087432","role":"Officer (EVP, GC & Secretary)","n_filings":2,"first_seen":"2014-06-03","last_seen":"2014-09-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001145404","name":"CORNERSTONE THERAPEUTICS INC","url":"/issuer/0001145404","role":"Officer (EVP, General Counsel)","n_filings":4,"first_seen":"2010-11-02","last_seen":"2011-07-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001012270","name":"COLLAGENEX PHARMACEUTICALS INC","url":"/issuer/0001012270","role":"Officer (VP, G. Counsel and Corp. Sec)","n_filings":5,"first_seen":"2005-06-27","last_seen":"2007-11-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001304113","retrieved_at":"2026-08-21T20:20:38+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}